J7527 HCPCS Level II code: Everolimus, oral, 0.25 mg
J7527 is the HCPCS code for “Everolimus, oral, 0.25 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7527Everolimus, oral, 0.25 mg
Short description: Oral everolimus
HCPCS · United States
Medicare details
The indicators CMS publishes with J7527 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Immunosuppressive drugs
- BETOS category
- Immunizations/Vaccinations
- Added
- Jan 1, 2013
Where J7527 sits
- 1J codesDrugs administered other than orally
- 2Active code J7527Everolimus, oral, 0.25 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7527 mean?
J7527 is the HCPCS code for “Everolimus, oral, 0.25 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7527?
CMS lists J7527’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7527
All J codesJ7519Injection, mycophenolate mofetil, 10 mgJ7520Sirolimus, oral, 1 mgJ7521Tacrolimus, granules, oral suspension, 0.1 mgJ7524Mycophenolate mofetil, oral, 5 mgJ7525Tacrolimus, parenteral, 5 mgJ7526Injection, mycophenolate mofetil, 5 mgJ7528Mycophenolate mofetil, for suspension, oral, 100 mgJ7529Mycophenolate mofetil, for suspension, oral, 5 mgJ7530Mycophenolate mofetil (myhibbin), oral suspension, 5 mgJ7531Prednisolone sodium phosphate, orally disintegrating tablet, 1 mgJ7599Immunosuppressive drug, not otherwise classifiedJ7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg